Achillion Pharmaceuticals is a biopharmaceutical company focused on the discovery, development, and commercialization of treatments for infectious diseases. The company is primarily engaged in the development of antivirals for the treatment of chronic hepatitis C infection (HCV), and the development of antibacterials for the treatment of resistant bacterial infections. ACHN currently is developing four drug candidates for the treatment of HCV. For more information, visit the company’s Web site at:  www.achillion.com

Noble Financial Capital Markets, an equity research driven, full-service, investment banking boutique, is hosting its ninth annual equity conference at The Hard Rock Hotel in Ft. Lauderdale, FL. Attended by institutional investors from across North America, the event features 135 public company executive teams with an emphasis on healthcare, technology, defense, and new-media / entertainment sectors.

Let us hear your thoughts below: